We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cryo-Save | LSE:CRYO | London | Ordinary Share | NL0009272137 | ORD EUR0.10 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 420.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCRYO RNS Number : 5972H Cryo-Save Group NV 24 February 2010 24 February 2010 Cryo-Save Group NV, (AIM: CRYO), Europe's largest adult stem cell storage bank, will be publishing its Full Year results for the 12 months ended 31 December 2009 on Monday, 22 March 2010. A presentation for analysts will be held at 9.30am on 22 March at the offices of College Hill, The Registry, Royal Mint Court, London, EC3N 4QN. Enquiries: +-------------------------------+----------------------------+ | Cryo-Save Group | + 31 (0) 575 548 998 | +-------------------------------+----------------------------+ | Marc Waeterschoot, Chief | | | Executive | | | Arnoud van Tulder, Chief | | | Financial Officer | | +-------------------------------+----------------------------+ | | | +-------------------------------+----------------------------+ | Daniel Stewart & Company plc | + 44 (0) 20 7776 6550 | +-------------------------------+----------------------------+ | Simon Leathers / Emma Earl | | +-------------------------------+----------------------------+ | | | +-------------------------------+----------------------------+ | College Hill | + 44 (0) 20 7457 2020 | +-------------------------------+----------------------------+ | Adrian Duffield/Rozi Morris | | +-------------------------------+----------------------------+ About Cryo-Save With more than 120,000 samples saved, Cryo-Save is the leading stem cell bank in Europe and one of the fastest growing in the world. Driven by its international business strategy, Cryo-Save is now represented in 38 countries on three continents and has state-of-the-art processing facilities in Belgium, Germany, Dubai, India and France (under construction). Cryo-Save sets the highest quality standards in stem cell storage, as it aims to make an important contribution to conquer possible life-threatening diseases in the future. As a service to the public, Cryo-Save offers a Cost-free Family Donation Programme, free of charge, to families wishing to store their newborn's umbilical cord blood stem cells for a family member diagnosed with a life-threatening disease treatable by stem cells. The company is committed to further improve stem cell cryopreservation techniques, by participating in European Commission funded projects, in Universities and Hospitals. This information is provided by RNS The company news service from the London Stock Exchange END NORKZLBLBLFFBBX
1 Year Cryo-Save Chart |
1 Month Cryo-Save Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions